Deloitte’s Path to 21st Century Cures A Call to Action

Our country has had a strong commitment to life sciences research and development R&D for new treatments and cures. For the past two decades, the U.S. was the world’s leading funder and life sciences innovator – providing up to 70 to 80 percent of global life sciences R&D funding.